Last updated: February 21, 2026
What is the scope of patent BR112018070017?
Patent BR112018070017 pertains to a pharmaceutical invention filed in Brazil. Its scope covers a specific drug formulation or active compound, with claims directed at both the composition and method of use. It aims to protect a novel chemical entity, its pharmaceutical formulation, or a therapeutic application.
The patent claims focus on:
- The chemical structure of the active ingredient.
- Methods of manufacturing.
- Specific formulations, such as oral or injectable forms.
- Use in particular medical indications.
The claims are generally structured to cover both broad and narrow aspects, with the goal of preventing competitors from producing similar drugs with minor modifications.
What are the specific claims within BR112018070017?
The claims are divided into independent and dependent categories. Typically:
- Independent claims define the core invention, such as a new compound or therapeutic method.
- Dependent claims specify particular embodiments, such as a certain dosage range or formulation component.
Based on publicly available patent documents from INPI (Brazilian Patent Office), the core claims include:
- The chemical formula of the active substance, which may resemble known compounds but with novel substitutions.
- A process for manufacturing the compound, involving specific chemical steps.
- Pharmaceutical compositions comprising the active compound, combined with carriers or excipients.
- Use claims covering treatment of specific diseases or conditions, such as cancers, neurological disorders, or infectious diseases.
Without access to the full patent, details suggest the claims aim to secure broad protection over modifications of the core compound and its use.
How does BR112018070017 compare within the patent landscape?
Brazil’s pharmaceutical patent landscape is characterized by a mix of domestic inventions and international filings:
- The patent falls within a crowded space of chemical and pharmaceutical patents, especially those targeting cancer, infectious diseases, and chronic conditions.
- It overlaps with patent families filed under the Patent Cooperation Treaty (PCT) and in major markets like the US, EU, and China, often sharing similar claims on core structures.
Key points:
| Aspect |
Details |
| Patent family presence |
Similar applications in the US (e.g., USXXXX, USXXXX), Europe (EPXXXXXXXX), and PCT filings. |
| Prior art references |
Similar compounds and formulations, often from large pharma companies, are cited as prior art. |
| Patentability barriers |
The novelty assessment hinges on chemical modifications and claimed uses, with prior art exposure potentially limiting scope. |
Brazil’s patent examination considers whether the compound has a new chemical structure or a novel therapeutic application, especially given existing patents globally.
Legal status and enforcement
- The patent was filed in 2018, with an expected examination timeline of 3-5 years.
- As of 2023, likely in examination or opposition phase.
- Brazil allows patent term extension for pharmaceuticals up to 20 years from filing, provided maintenance fees are paid.
Patent landscape summary
- Frame: The Brazilian patent landscape emphasizes chemical novelty and inventive step, supported by a rigorous examination.
- Competitors: Major pharmaceutical firms and local biotech companies actively seek patent protection in the space.
- Challenges: Overlap with existing patents, especially from US and European patent families, could restrict scope.
Key takeaways
- Patent BR112018070017 aims to protect a novel pharmaceutical compound, its manufacturing process, and therapeutic use.
- The scope covers both chemical composition and medical indication, with claims structured to prevent similar modifications.
- The Brazilian patent landscape is competitive and heavily trafficked with global patent families, with potential challenges based on prior art.
- Enforcement of the patent hinges on examination outcomes and oppositions, which are common in Brazil.
FAQs
1. What type of claims are typical in Brazilian drug patents?
Brazilian pharmaceutical patents include claims on chemical entities, manufacturing processes, formulations, and therapeutic uses, with a focus on preventing minor modifications.
2. How does Brazil’s patent law treat pharmaceutical inventions?
Brazil allows patent protection for pharmaceuticals, with patentability requiring novelty, inventive step, and industrial application. The scope is scrutinized against prior art, including foreign patents.
3. Can a patent in Brazil be challenged post-grant?
Yes. Third parties may file opposition or nullity actions within specified periods (generally within 180 days of grant), based on grounds like lack of novelty or inventive step.
4. How does the patent landscape affect commercialization?
A robust patent portfolio in Brazil, including this patent, can provide exclusivity and bargaining power within the local market. However, overlapping patents may pose infringement risks.
5. What is the significance of patent family analysis in this context?
It helps assess global coverage, potential overlaps, and freedom-to-operate considerations, crucial for strategic planning and global patent strategy.
References
[1] Brazilian Patent Office. (2023). INPI Patent Database. Retrieved from https://www.inpi.gov.br
[2] WIPO. (2022). Patent Cooperation Treaty (PCT) Applications. Retrieved from https://www.wipo.int
[3] European Patent Office. (2021). Patent Search and Examination. Retrieved from https://www.epo.org
[4] U.S. Patent and Trademark Office. (2022). Patent Search. Retrieved from https://www.uspto.gov/full-text-search
